Literature DB >> 8277178

Cryptosporidium parvum infection of intestinal epithelium: morphologic and functional studies in an in vitro model.

R B Adams1, R L Guerrant, S Zu, G Fang, J K Roche.   

Abstract

A monolayer of mature polarized colonic epithelial cells (T84) able to generate and maintain a barrier to macromolecular flow was used to study pathophysiologic events that occur on microvillus cell exposure to Cryptosporidium parvum. By 24-48 h, several life cycle forms were seen in parasitophorous vacuoles near the apical cell surface, along with a time- and oocyst dose-dependent reduction in epithelial barrier function. As few as 10(5) organisms constituted a successful infecting dose, and heat inactivation of organisms markedly reduced the monolayer barrier alteration. Horseradish peroxidase flux studies demonstrated a substantial increase in macromolecular permeability of the monolayer, and lactate dehydrogenase determinations indicated modest injury of the T84 epithelial cells on exposure to oocysts. Thus, disruption of the epithelial cell barrier, not just opening of transcellular channels for ion flow as reported previously, is responsible for the effects of C. parvum oocysts on intestinal epithelium.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8277178     DOI: 10.1093/infdis/169.1.170

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  16 in total

1.  Short-term exposure to membrane-active antibiotics inhibits Cryptosporidium parvum infection in cell culture.

Authors:  A Giacometti; O Cirioni; M S Del Prete; F Barchiesi; G Scalise
Journal:  Antimicrob Agents Chemother       Date:  2000-12       Impact factor: 5.191

Review 2.  In vitro cultivation of cryptosporidium species.

Authors:  Michael J Arrowood
Journal:  Clin Microbiol Rev       Date:  2002-07       Impact factor: 26.132

3.  Transforming growth factor beta1 ameliorates intestinal epithelial barrier disruption by Cryptosporidium parvum in vitro in the absence of mucosal T lymphocytes.

Authors:  J K Roche; C A Martins; R Cosme; R Fayer; R L Guerrant
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

4.  Cytotoxic T cells in AIDS colonic cryptosporidiosis.

Authors:  D Reijasse; N Patey-Mariaud de Serre; D Canioni; M Huerre; E Haddad; M Leborgne; S Blanche; N Brousse
Journal:  J Clin Pathol       Date:  2001-04       Impact factor: 3.411

5.  Comparative evaluation of several techniques for purification of Cryptosporidium parvum oocysts from rat feces.

Authors:  P Suresh; J E Rehg
Journal:  J Clin Microbiol       Date:  1996-01       Impact factor: 5.948

Review 6.  Cryptosporidium pathogenicity and virulence.

Authors:  Maha Bouzid; Paul R Hunter; Rachel M Chalmers; Kevin M Tyler
Journal:  Clin Microbiol Rev       Date:  2013-01       Impact factor: 26.132

7.  Novel in vitro and in vivo models and potential new therapeutics to break the vicious cycle of Cryptosporidium infection and malnutrition.

Authors:  Lourrany B Costa; Francisco Jose Noronha; James K Roche; Jesus Emmanuel Sevilleja; Cirle A Warren; Reinaldo Oriá; Aldo Lima; Richard L Guerrant
Journal:  J Infect Dis       Date:  2012-03-26       Impact factor: 5.226

8.  Cryptosporidium parvum infection of Caco-2 cell monolayers induces an apical monolayer defect, selectively increases transmonolayer permeability, and causes epithelial cell death.

Authors:  J K Griffiths; R Moore; S Dooley; G T Keusch; S Tzipori
Journal:  Infect Immun       Date:  1994-10       Impact factor: 3.441

9.  Detection of epithelial-cell injury, and quantification of infection, in the HCT-8 organoid model of cryptosporidiosis.

Authors:  Cirle Alcantara Warren; Raul V Destura; Jesus Emmanuel A D Sevilleja; Luis F Barroso; Humberto Carvalho; Leah J Barrett; Alison D O'Brien; Richard L Guerrant
Journal:  J Infect Dis       Date:  2008-07-01       Impact factor: 5.226

10.  Disruption of colonic barrier function and induction of mediator release by strains of Campylobacter jejuni that invade epithelial cells.

Authors:  Johannes Beltinger; Jo del Buono; Maeve M Skelly; John Thornley; Robin C Spiller; William A Stack; Christopher J Hawkey
Journal:  World J Gastroenterol       Date:  2008-12-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.